Licensed vaccine
VAQTA
FDA-licensed vaccine · Merck Sharp & Dohme Corp. · STN BL 103606
Key facts
| Trade name | VAQTA |
|---|---|
| Proper name | Hepatitis A Vaccine, Inactivated |
| Manufacturer | Merck Sharp & Dohme Corp. |
| Submission tracking number (STN) | BL 103606 |
| FDA product areas | Biologics, Vaccines |
| Recent FDA documents | October 23, 2020 Approval Letter - VAQTA, Patient Information - VAQTA, December 20, 2018 Approval Letter - VAQTA, Package Insert - VAQTA, Supporting Documents older than three years - VAQTA |
| FDA page updated | Oct 26, 2020 |
| FDA product page | fda.gov |
At a glance
- 1–9 FDA approval letters
- 1–9 Supporting documents
- 1–9 Product information documents
- Yes Document full text searchable in Orca1
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA-licensed vaccines
The FDA's CBER licenses vaccines for use in the United States. Each product page links the approval letters, package inserts and supporting documents for that vaccine.
Source: U.S. Food and Drug Administration (FDA), Center for Biologics Evaluation and Research (CBER), Vaccines Licensed for Use in the United States · Source date: